05:45 PM EST, 01/13/2025 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on January 08, 2025, sold 40,000 shares in Recursion Pharmaceuticals ( RXRX ) for $287,200. Following the Form 4 filing with the SEC, Gibson has control over a total of 736,633 shares of the company, with 736,633 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183025000010/xslF345X05/wk-form4_1736807155.xml